Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCZ | Q05513 | 2/20 | 0.54 |
| ▸ | GABBR2 | O75899 | 3/20 | 0.51 |
| ▸ | GABBR1 | Q9UBS5 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | FNTA | P49354 | 1/20 | 0.49 |
| ▸ | FNTB | P49356 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL657182 | 0.90 | PRKCZ (0.48) | PRKCZGABBR2GABBR1LMNACYP2C9 | |
| SCHEMBL8798403 | 0.90 | PRKCZ (0.48) | PRKCZGABBR2GABBR1LMNACYP2C9 | |
| SCHEMBL7633288 | 0.90 | GABBR2 (0.68) | PRKCZGABBR2GABBR1LMNACYP2C9 | |
| SCHEMBL8913116 | 0.88 | PRKCZ (0.49) | PRKCZGABBR2GABBR1LMNACYP2C9 | |
| Hydrochloric Acid SCHEMBL560490 | 0.88 | GABBR2 (0.66) | PRKCZGABBR2GABBR1LMNACYP2C9 | |
| SCHEMBL12268167 | 0.87 | FNTA (0.47) | PRKCZLMNAFNTAFNTBFFAR1 | |
| SCHEMBL8911597 | 0.87 | PRKCZ (0.48) | PRKCZGABBR2GABBR1LMNACYP2C9 | |
| SCHEMBL8067305 | 0.85 | PRKCZ (0.47) | PRKCZGABBR2GABBR1LMNACYP2C9 | |
| SCHEMBL8067302 | 0.85 | PRKCZ (0.47) | PRKCZGABBR2GABBR1LMNACYP2C9 | |
| SCHEMBL7728006 | 0.85 | FFAR1 (0.50) | PRKCZTSHRFNTAFNTBFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140242651-A1 | ENZYMATICALLY CATALYZED METHOD OF PREPARING MONO-ACYLATED POLYOLS | BASF SE (DE) | 2014-08-28 | — | — | US | disclosed |
| US-8715970-B2 | Enzymatically catalyzed method of preparing mono-acylated polyols | BASF SE (DE) | 2014-05-06 | — | — | US | disclosed |
| EP-2478094-A1 | AN ENZYMATICALLY CATALYZED METHOD OF PREPARING MONO-ACYLATED POLYOLS | BASF SE (DE) | 2012-07-25 | — | — | EP | disclosed |
| US-20120171738-A1 | ENZYMATICALLY CATALYZED METHOD OF PREPARING MONO-ACYLATED POLYOLS | BASF SE (DE) | 2012-07-05 | — | — | US | disclosed |
| WO-2011033039-A1 | AN ENZYMATICALLY CATALYZED METHOD OF PREPARING MONO-ACYLATED POLYOLS | BASF SE (DE) | 2011-03-24 | — | — | WO | disclosed |
| EP-0848706-B1 | SUBSTITUTED BENZENE-FUSED HETEROCYCLICS AS NEUROKININ ANTAGONISTS | SCHERING CORP (US) | 2003-02-05 | — | — | EP | disclosed |
| US-6410306-B1 | PREPARING PREFERENTIAL ENANTIMORPHS; OBTAIN CHEMICAL INTERMEDIATE, INCUBATE WITH ENZYMES, RECOVER PREFERENTIAL ENANTIMORPHS | SCHERING CORPORATION | 2002-06-25 | — | — | US | disclosed |
| EP-0773929-B1 | PIPERIDINE DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORP (US) | 2001-10-31 | — | — | EP | disclosed |
| EP-0848706-A1 | SUBSTITUTED BENZENE-FUSED HETERO- AND CARBOCYCLICS AS NEUROKININ ANTAGONISTS | SCHERING CORPORATION (US) | 1998-06-24 | — | — | EP | disclosed |
| EP-0808303-A1 | 5-(4-SUBST.-PIPERIDINYL-1)-3-ARYL-PENTANOIC ACID DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONIST | ZENECA LIMITED (GB) | 1997-11-26 | — | — | EP | disclosed |
| US-5691362-A | ANTIHISTAMINES, BRONCHODILATORS, ANTIINFLAMMATORY AGENTS, GASTROINTESTINAL DISORDERS | SCHERING-PLOUGH CORPORATION (US) | 1997-11-25 | — | — | US | disclosed |
| US-5654316-A | Piperidine derivatives as neurokinin antagonists | SCHERING CORPORATION (US) | 1997-08-05 | — | — | US | disclosed |
| EP-0773929-A1 | PIPERIDINE DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORPORATION (US) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996039383-A1 | SUBSTITUTED BENZENE-FUSED HETERO- AND CARBOCYCLICS AS NEUROKININ ANTAGONISTS | SCHERING CORPORATION (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996039386-A1 | PIPERIDINE DERIVATIVES AS NEUROKININ ANTAGONISTS | SCHERING CORPORATION (US) | 1996-12-12 | — | — | WO | disclosed |
| WO-1996024582-A1 | 5-(4-SUBST.-PIPERIDINYL-1)-3-ARYL-PENTANOIC ACID DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONIST | ZENECA LIMITED (GB) | 1996-08-15 | — | — | WO | disclosed |
| EP-0518939-A1 | ANTIARRHYTHMIC AGENTS | BTG INTERNATIONAL LIMITED (GB) | 1992-12-23 | — | — | EP | disclosed |
| WO-1991013865-A1 | ANTIARRHYTHMIC AGENTS | ISIS INNOVATION LIMITED (GB) | 1991-09-19 | — | — | WO | disclosed |